Moderna’s new vaccine targets COVID-19, the flu, and RSV
Moderna is developing a combination vaccine to protect against COVID-19, seasonal influenza, and respiratory syncytial virus.
Study: COVID-19 booster shots dramatically reduce infection risk
A large COVID-19 booster shot study in Israel found that a third dose significantly increased seniors’ protection against the coronavirus.
UK researchers are growing the Delta variant for human challenge trials
Responding to the variant’s rise, UK researchers are growing the Delta variant for trials.
One antibody stops all strains of COVID-19 from infecting cells
A newly discovered antibody can neutralize all strains of COVID-19 and every other sarbecovirus known to infect humans.
Antibody cocktail highly effective at preventing COVID-19
An antibody cocktail developed by biopharmaceutical company AstraZeneca was highly effective at preventing symptomatic COVID-19 infections.
India’s DNA vaccine for COVID-19 gets emergency approval
India has granted emergency approval to the world's first DNA vaccine for COVID-19.
Pfizer’s shot is the first FDA-approved COVID-19 vaccine
Pfizer’s shot has become the first FDA-approved COVID-19 vaccine, making the transition from emergency use authorization on August 23.
Beyond Sunday Service: How one Montgomery church is bringing health equity to their community4:03
A grassroots approach to vaccine education is happening in the heart of the civil rights movement in Alabama. Does this church hold the key to overcoming medical mistrust?
New treatment may prevent heart damage from COVID-19
An experimental drug that stopped the coronavirus from entering cells in heart organoids may be able to prevent heart damage from COVID-19.
Pfizer has manufactured the first batch of Delta variant vaccines
Pharma giant Pfizer has already developed and manufactured ingredients for a COVID-19 vaccine targeting the highly contagious Delta variant.